Pertinax
2015
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Early Stage VC
LATEST DEAL TYPE
$447K
LATEST DEAL AMOUNT
5
INVESTORS
Description
Developer of a dentistry technology intended to improve the efficacy of chlorhexidine-based products. The company's technology develops a chlorhexidine-based antimicrobial agent for dentistry and medicine treatment and prevention of bacterial infection in teeth, enabling healthcare practitioners to avail an innovative range of controlled release antimicrobial materials.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Primary Office
- Future Space, UWE North Gate
- Filton Road
- Bristol BS34 8RB
- England, United Kingdom
+44 07775 000000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Pertinax’s full profile, request a free trial.
Pertinax Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC | 21-Mar-2019 | $447K | 00.000 | 00.000 | Completed | Generating Revenue |
| 5. Early Stage VC | 23-Jan-2018 | 00.00 | 00.000 | 00.000 | Completed | Generating Revenue |
| 4. Seed Round | 15-Mar-2017 | 00.000 | 00.000 | 00.000 | Completed | Startup |
| 3. Early Stage VC | 11-Apr-2016 | 00000 | 00000 | 00.000 | Completed | |
| 2. Grant | 11-Mar-2016 | $768K | Completed | Startup | ||
| 1. Grant | 23-Apr-2015 | $37.1K | Completed | Startup |
Pertinax Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| C Ordinary | 00,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| A Ordinary | 00,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| A Ordinary | 39,000 | $0.000132 | $21.1 | $21.1 | 1x | $21.1 | 11.66% | |
| A Ordinary | 36,958 | $0.000132 | $15.14 | $15.14 | 1x | $15.14 | 11.05% |
Pertinax Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Perivoli Innovations Trust | Other | Minority | 000 0000 | 000000 0 | ||
| Mercia Asset Management | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Innovate UK | Government | 000 0000 | 000000 0 | |||
| SETsquared Partnership | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | ||
| The Armourers and Brasiers | Not-For-Profit Venture Capital | 000 0000 | 000000 0 |
Pertinax Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Michele Barbour Ph.D | Chief Executive Officer & Founder | ||
| Stuart Gibson | Board Member & Chief Financial Officer | ||
| Rosalind Darby | Director |
1 Former Executive
You’re viewing 3 of 4 executives. Get the full list »Pertinax Board Members (3)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Michele Redmond | Pertinax | Board Member | 000 0000 | |
| Stuart Gibson | Pertinax | Board Member & Chief Financial Officer | 000 0000 |
1 Former Board Member
You’re viewing 2 of 3 board members. Get the full list »